Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
cannabinoids
Biotech
Cannabinoid-focused drugmaker InMed backs away from H&W sector
Jumping into the health and wellness sector once seemed like an easy win for some pharma companies, but tough times are extending beyond biotech.
James Waldron
Sep 9, 2022 7:45am
Anebulo drug reduces cannabinoid intoxication in phase 2 study
Jul 5, 2022 12:39pm
Cannabidiol shows promise against superbugs
Jun 24, 2019 12:11pm
Corbus nets over 600 cannabinoid compounds, to test 1-2 per year
Sep 20, 2018 9:32am
Auxly Cannabis to acquire CRO KGK for $12.3M
Aug 29, 2018 12:50pm
GB Sciences to test cannabis-based therapies in humans
Jul 18, 2017 4:46pm